Brief: Quince Therapeutics Appoints William Whitehouse To Scientific Advisory Board
23/01/2025 22:56
Jan 23 (Reuters) - Quince Therapeutics Inc QNCX.O :
* QUINCE THERAPEUTICS APPOINTS RENOWNED PEDIATRIC
NEUROLOGIST DR.
WILLIAM WHITEHOUSE TO SCIENTIFIC ADVISORY BOARD
Source text: ID:nBw8VRyZna
Further company coverage: QNCX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IRulya Therapeutics
See all newsBrief: Quince Therapeutics - Changes Name To Irulya Therapeutics
Brief: Quince Therapeutics - Appoints Brigette Roberts As CEO Effective October 8, 2026
Quince Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Quince Therapeutics Reports Second Quarter 2026 Financial Results And Corporate Update
Quince Therapeutics Q2 net loss widens on acquisition charges